SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression
Proposed model of SALL4’s role in gastric cancer angiogenesis. SALL4 functions as a transcription factor that binds to VEGF-A, B, and C promoters and activates their expression. Exosomal delivery of si-SALL4-B and thalidomide results in targeted inhibition of SALL4-B and VEGF-A, B, and C expression, leading to suppression of gastric cancer angiogenesis
Publication
SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression. (2023) Fatma A. Abouelnazar, et al. Cancer Cell Int. 2023;23:149. Figure: F9.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | VEGF-A,B,C | VEGFC | ncbigene_symbol | VEGFC | 7424 |
| Homo sapiens | Primates | VEGF-A,B,C | VEGFA | ncbigene_symbol | VEGFA | 7422 |
| Homo sapiens | Primates | VEGF-A,B,C | VEGFB | ncbigene_symbol | VEGFB | 7423 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Thalidomide | Thalidomide | mesh:D013792 | thalidomide | chebi:9513 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| Cancer | NA | mesh:D009369 |